- Home
- / Cerenis Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Cerenis Therapeutics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
€1.2
2024-10-29
Market Capitalization
€42.7 M
2024-10-28
Revenue
€4.1 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| EUR | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 174.0K | 648.0K | 5.3M | 4.6M | 4.6M | 4.1M | ||
| Cost of goods sold | 237.0K | 2.0M | 887.0K | 1.3M | 1.2M | |||
| Gross profit | 174.0K | 441.0K | 3.3M | 3.9M | 3.3M | 2.8M | ||
| Gross profit margin, % | 100.0% | 68.1% | 62.3% | 83.0% | 71.5% | 69.8% | ||
| Operating expense total | 6.5M | 2.2M | 2.9M | 6.3M | 6.8M | 6.7M | 7.2M | 7.8M |
| Depreciation and amortization | 39.0K | 285.0K | 80.0K | 119.0K | 505.0K | 522.0K | 508.0K | 490.0K |
| EBITDA | (6.3M) | (2.2M) | (2.9M) | (5.8M) | (3.5M) | (2.9M) | (4.0M) | (5.0M) |
| EBITDA margin, % | -3619.0% | -900.2% | -66.3% | -62.3% | -86.9% | -122.7% | ||
| EBIT | (7.1M) | (2.5M) | (3.0M) | (6.0M) | (4.1M) | (3.4M) | (4.5M) | (5.5M) |
| EBIT margin, % | -4052.9% | -918.5% | -78.2% | -73.5% | -98.1% | -136.3% | ||
| Interest income | 923.0K | |||||||
| Interest expense | 148.0K | 419.0K | 95.0K | 124.0K | 241.0K | 218.0K | 61.0K | 109.0K |
| Pre tax profit | (6.3M) | 1.9M | (1.9M) | (5.8M) | (4.2M) | (3.5M) | (4.4M) | (5.5M) |
| Income tax expense | 1.0K | 38.0K | 9.0K | |||||
| Net Income | (6.3M) | 1.8M | (1.9M) | (5.8M) | (4.2M) | (3.5M) | (4.4M) | (5.5M) |